发明名称 |
TARGETING EN2, PAX2, AND/OR DEFB1 FOR TREATMENT OF PROSTATE CONDITIONS |
摘要 |
The present invention relates to methods and compositions for treating a prostate condition in a subject. The method comprises administering to the subject a subject effective amount of a pharmaceutical composition having a first agent that inhibits EN2 expression and/or EN2 activity and a second agent that inhibits PAX2 expression and/or PAX2 activity. The pharmaceutical composition may further comprise a third agent that enhances DEFB1 expression or activity.
|
申请公布号 |
US2012157508(A1) |
申请公布日期 |
2012.06.21 |
申请号 |
US201113310940 |
申请日期 |
2011.12.05 |
申请人 |
DONALD CARLTON D.;PHIGENIX, INC. |
发明人 |
DONALD CARLTON D. |
分类号 |
A61K31/7088;A61K31/713;A61P35/00 |
主分类号 |
A61K31/7088 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|